MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lummis, S. C.
Right arrow Articles by Martin, I. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lummis, S. C.
Right arrow Articles by Martin, I. L.

Solubilization, purification, and functional reconstitution of 5- hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells

SC Lummis and IL Martin

MRC Molecular Neurobiology Unit, MRC Centre, Cambridge, UK.

5-Hydroxytryptamine3 (5-HT3) receptors from N1E-115 neuroblastoma cells were solubilized using 1.1% n-octylglucoside; five other detergents were less effective. Purification was achieved by affinity chromatography using immobilized GR119566X and biospecific elution with quipazine. Saturation analyses with [3H] GR67330 binding revealed high affinity binding to homogeneous populations of sites in both the solubilized (Kd = 0.05 +/- 0.02 nM) and purified (Kd = 0.10 +/- 0.04 nM) preparations. Competition experiments indicated that the solubilized and purified receptor preparations retained the characteristics observed in N1E-115 cells in vivo. Polyacrylamide gel electrophoresis of the purified receptor revealed a single protein band of 54.7 +/- 1.3 kDa. The purified receptor was incorporated into liposomes, and the functional integrity of the protein was demonstrated by measurement of m-chlorophenylbiguanide-stimulated 22Na uptake. Saturation analysis of the reconstituted preparation revealed a Kd of 0.24 +/- 0.07 nM and suggested that 0.2% of 5-HT3 receptors present in the original membrane preparation had been incorporated into liposomes.

Volume 41, Issue 1, pp. 18-23, 01/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J.-L. Baneres, D. Mesnier, A. Martin, L. Joubert, A. Dumuis, and J. Bockaert
Molecular Characterization of a Purified 5-HT4 Receptor: A STRUCTURAL BASIS FOR DRUG EFFICACY
J. Biol. Chem., May 27, 2005; 280(21): 20253 - 20260.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. J. Coultrap, H. Sun, T. E. Tenner Jr., and T. K. Machu
Competitive Antagonism of the Mouse 5-Hydroxytryptamine3 Receptor by Bisindolylmaleimide I, a "Selective" Protein Kinase C Inhibitor
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 76 - 82.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
T. Green, K. A. Stauffer, and S. C. R. Lummis
Expression of Recombinant Homo-oligomeric 5-Hydroxytryptamine(3) Receptors Provides New Insights into Their Maturation and Structure
J. Biol. Chem., March 17, 1995; 270(11): 6056 - 6061.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics